Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
US9624273B2 · kind B2 · utility
2Cited by
46References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2012 |
| Grant date | Apr 18, 2017 |
| Priority date | — |
| Expiry date | Nov 21, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16634
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. Highly effective vaccines and immunogenic compositions against HSV-2 which can be used therapeutically or prophylactically, are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.